508 related articles for article (PubMed ID: 4216248)
1. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
Hatunceva NV; Mironova MV; Ryapolova RG
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
[No Abstract] [Full Text] [Related]
2. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
[No Abstract] [Full Text] [Related]
3. [Comparison of oral and subcutaneous immunization against typhoid-paratyphoid fever (author's transl)].
Krasnoproshina LI
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):151-60. PubMed ID: 4216249
[No Abstract] [Full Text] [Related]
4. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
Arya SC; Agarwal N
Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
[No Abstract] [Full Text] [Related]
5. [Diagnostic importance of various methods of determining infectious O-antigenemia in patients with typhoid and paratyphoid fevers A and B].
Cherkasov VL; Rubtsov IV; Erovichenkov AA; Kulakov VN; Tregub AV
Ter Arkh; 1988; 60(11):35-8. PubMed ID: 2467391
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
7. Vaccines against typhoid fever.
Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
[TBL] [Abstract][Full Text] [Related]
8. [Typhoid vaccination from an immunological point of view].
Günther O
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1970; 65():1-14. PubMed ID: 4926019
[No Abstract] [Full Text] [Related]
9. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
Schwartz E
N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
[No Abstract] [Full Text] [Related]
10. [Diagnostic value of the slide coagglutination reaction in typhoid-paratyphoid diseases].
Belaia IuA; Prozorovskiĭ SV; Agafonov VI; Belaia OF; Kolkov VF
Voen Med Zh; 1987 Aug; (8):36-7. PubMed ID: 3118569
[No Abstract] [Full Text] [Related]
11. [The anti-Salmonella paratyphi B vaccination].
Dimache G; Vlădoianu IR; Dimache V; Popescu P; Antonescu O; Mitrea D
Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):477-86. PubMed ID: 4999244
[No Abstract] [Full Text] [Related]
12. General immunity reactions after oral administration of inactivated typhoid vaccines in man.
Karolcek J; Drăskovicová M; Georch D
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):143-50. PubMed ID: 4440523
[No Abstract] [Full Text] [Related]
13. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
Kheĭfets LB; Stanislavskiĭ ES; Levina LA
Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
[No Abstract] [Full Text] [Related]
14. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
[TBL] [Abstract][Full Text] [Related]
15. Enteric fever in Israel travelers: a nationwide study.
Arya SC; Agarwal N
J Travel Med; 2006; 13(5):327; author reply 328. PubMed ID: 16987137
[No Abstract] [Full Text] [Related]
16. Status of paratyphoid fever vaccine research and development.
Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
[TBL] [Abstract][Full Text] [Related]
17. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
Wahid R; Fresnay S; Levine MM; Sztein MB
Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480
[TBL] [Abstract][Full Text] [Related]
18. [Methodological and organizational aspects of detecting chronic carriers of typhoid and paratyphoid bacteria (review of the literature in 1960-1971)].
Priamukhina NS; Kolobova LF
Zh Mikrobiol Epidemiol Immunobiol; 1973 Aug; 50(8):32-8. PubMed ID: 4206260
[No Abstract] [Full Text] [Related]
19. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the Gruber-Widal and ELISA technics used to study Salmonella typhi and Salmonella paratyphi infections in patients].
Ayyildiz A; Demir Y; Tuncel E; Babacan M; Leloğlu S
Mikrobiyol Bul; 1986 Jan; 20(1):14-24. PubMed ID: 3088401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
